Testing effectiveness (Phase 2)Study completedNCT02980692What this trial is testingEfficacy and Safety Study of SUNPG1623Who this might be right forActive Psoriatic Arthritis Sun Pharmaceutical Industries Limited 391
Large-scale testing (Phase 3)Study completedNCT03895203What this trial is testingTest the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisWho this might be right forPsoriatic Arthritis UCB Biopharma SRL 852
Large-scale testing (Phase 3)Study completedNCT04711902What this trial is testingStudy of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.Who this might be right forPsoriatic Arthritis Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT00646386What this trial is testingStudy of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic ArthritisWho this might be right forArthritisPsoriatic Abbott 315
Large-scale testing (Phase 3)Study completedNCT01087788What this trial is testingCertolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic ArthritisWho this might be right forArthritis, Psoriatic UCB BIOSCIENCES GmbH 409
Large-scale testing (Phase 3)Ended earlyNCT05623345What this trial is testingPsoriatic Arthritis Study of IzokibepWho this might be right forPsoriatic Arthritis ACELYRIN Inc. 351
Early research (Phase 1)Study completedNCT02141763What this trial is testingMultiple Dose Study of UCB4940 in Subjects With Psoriatic ArthritisWho this might be right forPsoriatic Arthritis UCB Celltech 53
Testing effectiveness (Phase 2)Study completedNCT01988103What this trial is testingEfficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type PsoriasisWho this might be right forPsoriasisPsoriatic ArthritisPsoriasis Arthropatica Amgen 254
Large-scale testing (Phase 3)Study completedNCT00367237What this trial is testingRemicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)Who this might be right forArthritis, Psoriatic Merck Sharp & Dohme LLC 115
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06918743What this trial is testingTo Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II StudyWho this might be right forPsoriatic Subjects Jiangsu HengRui Medicine Co., Ltd. 147
Testing effectiveness (Phase 2)Ended earlyNCT01516957What this trial is testingAMG 827 in Subjects With Psoriatic ArthritisWho this might be right forPsoriatic Arthritis Bausch Health Americas, Inc. 168
Early research (Phase 1)Study completedNCT01539213What this trial is testingDistribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mgWho this might be right forHealthyPsoriasis Novartis Pharmaceuticals 16
Post-approval studies (Phase 4)Study completedNCT04183881What this trial is testingClinical Study of BrodalumabWho this might be right forPsoriasis VulgarisPsoriatic ArthritisPustular; Psoriasis, Palmaris Et Plantaris+1 more Kyowa Kirin Co., Ltd. 138
Testing effectiveness (Phase 2)Study completedNCT02349451What this trial is testingInvestigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)Who this might be right forPsoriatic Arthritis AbbVie 240
Testing effectiveness (Phase 2)Looking for participantsNCT06865105What this trial is testingStudy of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisWho this might be right forPsoriatic Arthritis AbbVie 120
Early research (Phase 1)Study completedNCT02303509What this trial is testingStudy to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic SubjectWho this might be right forPsoriasis UCB Pharma 57
Large-scale testing (Phase 3)Study completedNCT03104374What this trial is testingA Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic DrugWho this might be right forPsoriatic Arthritis AbbVie 642
Large-scale testing (Phase 3)Study completedNCT02376790What this trial is testingEtanercept and Methotrexate in Combination or as Monotherapy in Psoriatic ArthritisWho this might be right forPsoriatic Arthritis Amgen 851
Large-scale testing (Phase 3)Study completedNCT01519089What this trial is testingA Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic ArthritisWho this might be right forPsoriasis Pfizer 95
Testing effectiveness (Phase 2)Study completedNCT03963401What this trial is testingEvaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic ArthritisWho this might be right forPsoriatic Arthritis Pfizer 219